Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trichoton AT
- Development stage
- Unknown
- Lead developer
- Med Manor Organics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Trichoton AT is an oral dietary supplement developed and marketed by Med Manor Organics for the management of canities (premature graying of hair) and hair loss. Formulated as a film-coated tablet, it contains a combination of essential vitamins and minerals, including calcium pantothenate (Vitamin B5), folic acid, biotin (Vitamin B7), zinc, and copper. Calcium pantothenate is clinically associated with reversing or delaying the graying of hair, while biotin and folic acid support hair follicle health and structural integrity. Zinc and copper provide essential trace minerals that protect the scalp, support hair repair, and assist in melanin synthesis to maintain natural hair pigmentation.
- Brand names
- Trichoton AT
- Other names
- Trichoton AT TabletTrichoton AT Tablets
Beyond the preview
Go deeper on Trichoton AT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trichoton AT.